136 related articles for article (PubMed ID: 11674903)
1. What is the best treatment for slowing the progression to end-stage renal disease (ESRD) in African Americans with hypertensive nephropathy?
McConaghy JR
J Fam Pract; 2001 Sep; 50(9):744. PubMed ID: 11674903
[No Abstract] [Full Text] [Related]
2. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
[TBL] [Abstract][Full Text] [Related]
3. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
[TBL] [Abstract][Full Text] [Related]
4. Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
Toto RD
Curr Hypertens Rep; 2006 Oct; 8(5):409-12. PubMed ID: 16965728
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure control, drug therapy, and kidney disease.
Contreras G; Greene T; Agodoa LY; Cheek D; Junco G; Dowie D; Lash J; Lipkowitz M; Miller ER; Ojo A; Sika M; Wilkening B; Toto RD;
Hypertension; 2005 Jul; 46(1):44-50. PubMed ID: 15897360
[TBL] [Abstract][Full Text] [Related]
6. Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.
Thornley-Brown D; Wang X; Wright JT; Randall OS; Miller ER; Lash JP; Gassman J; Contreras G; Appel LJ; Agodoa LY; Cheek D
Arch Intern Med; 2006 Apr; 166(7):797-805. PubMed ID: 16606818
[TBL] [Abstract][Full Text] [Related]
7. Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.
Chen Y; Lipkowitz MS; Salem RM; Fung MM; Bhatnagar V; Mahata M; Nievergelt CM; Rao F; Mahata SK; Schork NJ; Hicks PJ; Bowden DW; Freedman BI; Brophy VH; O'Connor DT;
Am J Nephrol; 2010; 32(1):23-30. PubMed ID: 20484896
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial.
Douglas JG; Agodoa L
Kidney Int Suppl; 2003 Feb; (83):S74-6. PubMed ID: 12864879
[TBL] [Abstract][Full Text] [Related]
9. The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned?
Sica DA
J Clin Hypertens (Greenwich); 2003; 5(2):159-67. PubMed ID: 12671332
[TBL] [Abstract][Full Text] [Related]
10. Renal outcomes in hypertensive Black patients at high cardiovascular risk.
Weir MR; Bakris GL; Weber MA; Dahlof B; Devereux RB; Kjeldsen SE; Pitt B; Wright JT; Kelly RY; Hua TA; Hester RA; Velazquez E; Jamerson KA
Kidney Int; 2012 Mar; 81(6):568-76. PubMed ID: 22189843
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive drugs and renal protection.
Fukuda M; Usami T; Yoshida A; Kimura G
JAMA; 2003 Mar; 289(9):1102-3; author reply 1103. PubMed ID: 12622571
[No Abstract] [Full Text] [Related]
12. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Lea J; Greene T; Hebert L; Lipkowitz M; Massry S; Middleton J; Rostand SG; Miller E; Smith W; Bakris GL
Arch Intern Med; 2005 Apr; 165(8):947-53. PubMed ID: 15851648
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber MA; Franklin S; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T;
Ann Intern Med; 2006 Feb; 144(3):172-80. PubMed ID: 16461961
[TBL] [Abstract][Full Text] [Related]
14. Initial findings of the AASK: African Americans with hypertensive kidney disease benefit from an ACE inhibitor.
Rahman M
Cleve Clin J Med; 2003 Apr; 70(4):304-5, 309-10, 312. PubMed ID: 12701984
[TBL] [Abstract][Full Text] [Related]
15. Mixed messages on blood pressure goals.
Chobanian AV
Hypertension; 2011 Jun; 57(6):1039-40. PubMed ID: 21555679
[No Abstract] [Full Text] [Related]
16. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
Ruggenenti P; Perna A; Gherardi G; Garini G; Zoccali C; Salvadori M; Scolari F; Schena FP; Remuzzi G
Lancet; 1999 Jul; 354(9176):359-64. PubMed ID: 10437863
[TBL] [Abstract][Full Text] [Related]
17. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
18. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
19. Current strategies for management of hypertensive renal disease.
Moore MA; Epstein M; Agodoa L; Dworkin LD
Arch Intern Med; 1999 Jan; 159(1):23-8. PubMed ID: 9892326
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management.
Lash JP; Wang X; Greene T; Gadegbeku CA; Hall Y; Jones K; Kusek JW; Sika M; Unruh M;
Am J Kidney Dis; 2006 Jun; 47(6):956-64. PubMed ID: 16731290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]